药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Benzphetamine
Emedastine
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Emedastine.
Benzphetamine
Dexverapamil
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Dexverapamil.
Benzphetamine
Ondansetron
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Ondansetron.
Benzphetamine
Penfluridol
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Penfluridol.
Benzphetamine
Otilonium
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Otilonium.
Benzphetamine
Dexchlorpheniramine maleate
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Dexchlorpheniramine maleate.
Benzphetamine
Benidipine
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Benidipine.
Benzphetamine
Eperisone
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Eperisone.
Benzphetamine
Fendiline
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Fendiline.
Benzphetamine
Nilvadipine
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Nilvadipine.
Benzphetamine
Fluspirilene
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Fluspirilene.
Benzphetamine
Prenylamine
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Prenylamine.
Benzphetamine
Granisetron
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Granisetron.
Benzphetamine
Dexchlorpheniramine
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Dexchlorpheniramine.
Benzphetamine
Lorcainide
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Lorcainide.
Benzphetamine
Bunaftine
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Bunaftine.
Benzphetamine
Nizofenone
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Nizofenone.
Benzphetamine
Sultopride
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Sultopride.
Benzphetamine
Sitafloxacin
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Sitafloxacin.
Benzphetamine
Oxatomide
The risk or severity of QTc prolongation can be increased when Posaconazole is combined with Oxatomide.